Tech Company Financing Transactions
Just Biotherapeutics Funding Round
Just Biotherapeutics closed a $15 million Series A investment round on 9/22/2015. Backers included Arch Venture Partners, Lilly Asia Ventures and Merck Capital Ventures.
Transaction Overview
Company Name
Announced On
9/22/2015
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series A
Proceeds Purpose
The company intends to use the funds to design of innovative technologies that accelerate development and low cost manufacturing of complex biotherapeutics.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
401 Terry Ave. North
Seattle, WA 98109
USA
Seattle, WA 98109
USA
Phone
Website
Email Address
Overview
Just is an integrated design company focused on the technology of biotherapeutics, from molecule to manufacturing plant. We believe that technological innovation will accelerate biotherapeutic development and dramatically reduce the cost of these vital medicines.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Thomas
Chief Operating Officer
Victor Fung
Chief Scientific Officer
Dean Pettit
VP - Bus. Development
Vasant Gandhi
VP - Bus. Development
Carolina Rizo
VP - Engineering
Brian Horman
VP - Human Resources
Caroline Chan
Browse more venture capital transactions:
Prev: 9/22/2015: Rhone venture capital transaction
Next: 9/23/2015: Everyone Counts venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to record all VC transactions involving tech companies. VC investment data records on this site come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs